Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Liver Diseases

Free Subscription Articles published in Cancer Retrieve available abstracts of 44 articles: HTML format Text format

Single Articles

December 2011
1. CHAN SL , Mo FK, Wong CS, Chan CM, et al
   A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma.
   Cancer. 2011 Dec 16. doi: 10.1002/cncr.26726.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ARTINYAN A , Marshall CL, Balentine CJ, Albo D, et al
   Clinical outcomes of oncologic gastrointestinal resections in patients with cirrhosis.
   Cancer. 2011 Dec 13. doi: 10.1002/cncr.26682.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. TURLEY RS , Peng PD, Reddy SK, Barbas AS, et al
   Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
   Cancer. 2011 Nov 15. doi: 10.1002/cncr.26650.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. KASAI K , Ushio A, Kasai Y, Sawara K, et al
   Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma with portal venous invasion.
   Cancer. 2011 Nov 9. doi: 10.1002/cncr.26648.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
5. PRICE TR , Perkins SM, Sandrasegaran K, Henderson MA, et al
   Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma.
   Cancer. 2011 Oct 24. doi: 10.1002/cncr.26404.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. YOKOYAMA N , Otani T, Hashidate H, Maeda C, et al
   Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: Preliminary results of a prospective study.
   Cancer. 2011 Oct 11. doi: 10.1002/cncr.26594.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. XIE Q , Chen X, Lu F, Zhang T, et al
   Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
   Cancer. 2011 Oct 11. doi: 10.1002/cncr.26566.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. ZHAO YM , Zhou JM, Wang LR, He HW, et al
   HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection.
   Cancer. 2011 Oct 11. doi: 10.1002/cncr.26524.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. BROUQUET A , Overman MJ, Kopetz S, Maru DM, et al
   Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?
   Cancer. 2011;117:4484-92.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. PHILIP PA , Mahoney MR, Holen KD, Northfelt DW, et al
    Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer.
    Cancer. 2011 Sep 27. doi: 10.1002/cncr.26556.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. TANAKA K , Kumamoto T, Nojiri K, Takeda K, et al
    Postchemotherapy histological analysis of major intrahepatic vessels for reversal of attachment or invasion by colorectal liver metastases.
    Cancer. 2011 Sep 22. doi: 10.1002/cncr.26563.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. KIM DH , Park SE, Kim M, Ji YI, et al
    A functional single nucleotide polymorphism at the promoter region of cyclin A2 is associated with increased risk of colon, liver, and lung cancers.
    Cancer. 2011;117:4080-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. CHANG DT , Swaminath A, Kozak M, Weintraub J, et al
    Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
    Cancer. 2011;117:4060-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
14. FANG F , Chang R, Yang L
    Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo.
    Cancer. 2011 Aug 25. doi: 10.1002/cncr.26482.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. NATHAN H , Segev DL, Mayo SC, Choti MA, et al
    National trends in surgical procedures for hepatocellular carcinoma: 1998-2008.
    Cancer. 2011 Aug 25. doi: 10.1002/cncr.26501.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. ARGIRIS A , Ghebremichael M, Burtness B, Axelrod RS, et al
    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
    Cancer. 2011;117:3374-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
17. TSAI HW , Lin YJ, Lin PW, Wu HC, et al
    A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery.
    Cancer. 2011;117:2951-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
18. EDELINE J , Boucher E, Rolland Y, Vauleon E, et al
    Comparison of tumor response by response evaluation criteria in solid tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma.
    Cancer. 2011 Jun 28. doi: 10.1002/cncr.26255.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. FANG F , Yang L, Tao Y, Qin W, et al
    FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.
    Cancer. 2011 Jun 28. doi: 10.1002/cncr.26251.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
20. FARGES O , Fuks D, Le Treut YP, Azoulay D, et al
    AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group.
    Cancer. 2011;117:2170-7.
    PubMed     Text format     Related articles   
    
    
    
    
21. LAUTZ TB , Ben-Ami T, Tantemsapya N, Gosiengfiao Y, et al
    Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma.
    Cancer. 2011;117:1976-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
22. ZHU AX , Abrams TA, Miksad R, Blaszkowsky LS, et al
    Phase 1/2 study of everolimus in advanced hepatocellular carcinoma.
    Cancer. 2011 Apr 27. doi: 10.1002/cncr.26165.
    PubMed     Text format     Related articles   
    
    
    
    
23. KOMATSU S , Fukumoto T, Demizu Y, Miyawaki D, et al
    Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma.
    Cancer. 2011 Apr 14. doi: 10.1002/cncr.26134.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. DING T , Xu J, Zhang Y, Guo RP, et al
    Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection.
    Cancer. 2011 Apr 8. doi: 10.1002/cncr.26137.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. KIM BK , Kang WJ, Kim JK, Seong J, et al
    (18) F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
    Cancer. 2011 Apr 5. doi: 10.1002/cncr.26099.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. KIEFER MV , Albert M, McNally M, Robertson M, et al
    Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: A 2-center study.
    Cancer. 2011;117:1498-505.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
27. ROBBINS AS , Cox DD, Johnson LB, Ward EM, et al
    Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.
    Cancer. 2011 Mar 29. doi: 10.1002/cncr.26063.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. UCHINO K , Tateishi R, Shiina S, Kanda M, et al
    Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors.
    Cancer. 2011 Mar 22. doi: 10.1002/cncr.25960.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. LIU J , Yang Y, Zhang H, Zhao S, et al
    Longer leukocyte telomere length predicts increased risk of hepatitis b virus-related hepatocellular carcinoma: A case-control analysis.
    Cancer. 2011 Mar 8. doi: 10.1002/cncr.26015.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ELSAYES KM , Ellis JH, Elkhouly T, Ream JM, et al
    Diagnostic yield of percutaneous image-guided tissue biopsy of focal hepatic lesions in cancer patients: Ten percent are not metastases from the primary malignancy.
    Cancer. 2011 Mar 8. doi: 10.1002/cncr.25980.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. ISHIKAWA T , Higuchi K, Kubota T, Seki K, et al
    Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinoma.
    Cancer. 2011 Mar 1. doi: 10.1002/cncr.25989.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
32. KOH WP , Yuan JM, Wang R, Govindarajan S, et al
    Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma.
    Cancer. 2011 Feb 11. doi: 10.1002/cncr.25939.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
33. SUN W , Sohal D, Haller DG, Mykulowycz K, et al
    Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma.
    Cancer. 2011 Jan 24. doi: 10.1002/cncr.25889.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. BUSH DA , Kayali Z, Grove R, Slater JD, et al
    The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: A phase 2 prospective trial.
    Cancer. 2011 Jan 24. doi: 10.1002/cncr.25809.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. ALBERT M , Kiefer MV, Sun W, Haller D, et al
    Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol.
    Cancer. 2011;117:343-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. TSAI HW , Lin YJ, Lin PW, Wu HC, et al
    A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery.
    Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
37. KASEB AO , Hassan MM, Lin E, Xiao L, et al
    V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
38. FARGES O , Fuks D, Le Treut YP, Azoulay D, et al
    AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. LAUTZ TB , Ben-Ami T, Tantemsapya N, Gosiengfiao Y, et al
    Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KIEFER MV , Albert M, McNally M, Robertson M, et al
    Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
41. SHAH SA , Smith JK, Li Y, Ng SC, et al
    Underutilization of therapy for hepatocellular carcinoma in the medicare population.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
42. LOMBARDI G , Zustovich F, Farinati F, Cillo U, et al
    Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma: Results of a phase 2 study.
    Cancer. 2010 Aug 31. doi: 10.1002/cncr.25578.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. HUANG XY , Ke AW, Shi GM, Ding ZB, et al
    Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
44. MORIMOTO M , Numata K, Kondou M, Nozaki A, et al
    Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: